Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Carmichael

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
IUBMB Life|November 17, 2004
Gene expression profiling of p53(+/-) knockout and wild-type mice following diethylstilbestrol administrationMohd Nazil Salleh, Patimah Ismail, Abdul Salam Abdullah, et al.
Mutation Research|December 6, 2011
Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. I. Choice of cell typePaul Fowler, Katie Smith, Jamie Young, et al.
ALTEX|November 30, 2010
Assuring safety without animal testing: Unilever's ongoing research programme to deliver novel ways to assure consumer safetyCarl Westmoreland, Paul Carmichael, Matt Dent, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|March 18, 2014
Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. III: sensitivity of human cell types to known genotoxic agentsPaul Fowler, Robert Smith, Katie Smith, et al.
Mutation Research|May 19, 2012
Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. II. Importance of accurate toxicity measurementPaul Fowler, Robert Smith, Katie Smith, et al.
Plos One|September 17, 2013
Genomic phenotyping by barcode sequencing broadly distinguishes between alkylating agents, oxidizing agents, and non-genotoxic agents, and reveals a role for aromatic amino acids in cellular recovery after quinone exposureJ Peter Svensson, Laia Quirós Pesudo, Siobhan K McRee, et al.
BMC Systems Biology|October 8, 2011
Genomic phenotyping of the essential and non-essential yeast genome detects novel pathways for alkylation resistanceJ Peter Svensson, Laia Quirós Pesudo, Rebecca C Fry, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 13, 2021
Next generation risk assessment (NGRA): Bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling - A case study of doxorubicin with dose metrics considerationsHequn Li, Haitao Yuan, Alistair Middleton, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 29, 2020
The Alginate Immobilization of Metabolic Enzymes Platform Retrofits an Estrogen Receptor Transactivation Assay With Metabolic CompetenceChad Deisenroth, Danica E DeGroot, Todd Zurlinden, et al.
Environmental Toxicology and Pharmacology|November 30, 2019
Integrating in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling for chemical liver toxicity assessment-A case study of troglitazoneLin Yu, Hequn Li, Chi Zhang, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
IUBMB Life|November 17, 2004
Gene expression profiling of p53(+/-) knockout and wild-type mice following diethylstilbestrol administrationMohd Nazil Salleh, Patimah Ismail, Abdul Salam Abdullah, et al.
Mutation Research|December 6, 2011
Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. I. Choice of cell typePaul Fowler, Katie Smith, Jamie Young, et al.
ALTEX|November 30, 2010
Assuring safety without animal testing: Unilever's ongoing research programme to deliver novel ways to assure consumer safetyCarl Westmoreland, Paul Carmichael, Matt Dent, et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis|March 18, 2014
Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. III: sensitivity of human cell types to known genotoxic agentsPaul Fowler, Robert Smith, Katie Smith, et al.
Mutation Research|May 19, 2012
Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. II. Importance of accurate toxicity measurementPaul Fowler, Robert Smith, Katie Smith, et al.
Plos One|September 17, 2013
Genomic phenotyping by barcode sequencing broadly distinguishes between alkylating agents, oxidizing agents, and non-genotoxic agents, and reveals a role for aromatic amino acids in cellular recovery after quinone exposureJ Peter Svensson, Laia Quirós Pesudo, Siobhan K McRee, et al.
BMC Systems Biology|October 8, 2011
Genomic phenotyping of the essential and non-essential yeast genome detects novel pathways for alkylation resistanceJ Peter Svensson, Laia Quirós Pesudo, Rebecca C Fry, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|April 13, 2021
Next generation risk assessment (NGRA): Bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling - A case study of doxorubicin with dose metrics considerationsHequn Li, Haitao Yuan, Alistair Middleton, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 29, 2020
The Alginate Immobilization of Metabolic Enzymes Platform Retrofits an Estrogen Receptor Transactivation Assay With Metabolic CompetenceChad Deisenroth, Danica E DeGroot, Todd Zurlinden, et al.
Environmental Toxicology and Pharmacology|November 30, 2019
Integrating in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling for chemical liver toxicity assessment-A case study of troglitazoneLin Yu, Hequn Li, Chi Zhang, et al.
Pageof 4